Stockscreener 앱 받기
1.62
10.96%
0.16
시간 외 거래:
1.69
0.07
+4.32%
전일 마감가:
$1.46
열려 있는:
$1.48
하루 거래량:
221.86K
Relative Volume:
0.85
시가총액:
$4.31M
수익:
$1.31M
순이익/손실:
$-7.56M
주가수익비율:
-0.1574
EPS:
-10.2926
순현금흐름:
$-8.25M
1주 성능:
+17.39%
1개월 성능:
+16.55%
6개월 성능:
-52.30%
1년 성능:
-80.43%
1일 변동 폭
$1.4502
$1.79
1주일 범위
$1.22
$1.79
52주 변동 폭
$1.22
$10.77
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
명칭
60 Degrees Pharmaceuticals Inc
전화
202-327-5422
주소
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.62 | 3.96M | 1.31M | -7.56M | -8.25M | -10.29 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스
Top Executive Makes Bold Move With Fresh Buy in Pharma Stock - TipRanks
Insider Buying: Geoffrey Dow Acquires Additional Shares of 60 De - GuruFocus
60 degrees pharmaceuticals CEO buys $10,131 in stock - Investing.com
CEO Geoffrey Dow adds 7,350 SXTP shares in open-market buy - Stock Titan
60 Degrees Pharmaceuticals Licenses Patent to Produce Australian Chestnut Extract - marketscreener.com
Australian chestnut tree targeted for U.S. supplements in 60 Degrees Pharma deal - Stock Titan
60 Degrees Pharmaceuticals (SXTP) proposes 800K-share equity refresh, reverse split - Stock Titan
According to a document submitted to the U.S. Securities and Exchange Commission, the biopharmaceutical company 60 Degrees Pharmaceuticals, Inc. may submit a New Drug Application for its drug tafenoquine to the U.S. Food and Drug Administration bef - Bitget
60 Degrees details tafenoquine priority review voucher strategy - TipRanks
60 Degrees Pharmaceuticals to seek Priority Review Voucher if tafenoquine trial supports NDA - TradingView
60 Degrees Pharmaceuticals (SXTP) details potential NDA and FDA voucher path - Stock Titan
60 Degrees Pharmaceuticals Q1 2026 Earnings: EPS Falls Sharply Short of Estimates as Development Costs MountDebt Analysis Report - The Legal Advocate
SXTP Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue PhaseEarnings Revision Downgrade - newsline.com
SXTP Q1 2026 Earnings: Significant EPS Miss as Company Continues Pre-Revenue PhaseROE Trend Analysis - The Legal Advocate
60 Degrees Pharm 1Q Rev $162,000 >SXTP - Moomoo
60 Degrees Pharmaceuticals (SXTP) Slips 6% as Shares Test Key SupportNew Highs New Lows - newsline.com
60 Degrees Pharmaceuticals enrolls first patient in babesiosis trial - Investing.com
60 Degrees Pharmaceuticals enrolls first patient in babesiosis trial By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals Announces Early Enrollment of - GlobeNewswire
60 Degrees Pharmaceuticals Inc. (SXTP) Q1 2026 Earnings: EPS Misses Estimates, No Revenue YetFree Cash Flow Trends - The Legal Advocate
60 Degrees Pharma Nears FDA Deadline in Thin Holiday Trading - Bez Kabli
SXTP Q1 2026 Earnings: EPS Misses Estimates by Wide Margin Amid Operational ChallengesBuyback Announcement Report - The Legal Advocate
60 Degrees Pharmaceuticals (SXTP) Holds Near Support After Minor DeclineFlat Correction - Newser
60 Degrees Pharmaceuticals (SXTP) Dips 1.34% as Shares Test Support LevelSupport Level Bounce - Newser
60 Degrees Pharmaceuticals, Inc.Warrant (NQ: SXTPW - The Chronicle-Journal
SXTP Downgraded by HC Wainwright & Co. -- New Rating: Neutral - GuruFocus
60 Degrees Pharm Cut to Neutral From Buy by HC Wainwright & Co. - Moomoo
H.C. Wainwright Downgrades 60 Degrees Pharmaceuticals(SXTP.US) to Hold Rating - Moomoo
60 Degrees Pharmaceuticals (NASDAQ: SXTP) director files initial Form 3 insider report - Stock Titan
60 Degrees Pharmaceuticals appoints Eric Francois to board of directors By Investing.com - Investing.com Nigeria
60 Degrees Pharmaceuticals, Inc. Files Form 8-K with SEC – Company Details, NASDAQ Listing, and Compliance Highlights - Minichart
60 Degrees Pharmaceuticals appoints Eric Francois to board of directors - Investing.com
60 Degrees Pharmaceuticals appoints Eric Francois to board - TradingView
Eric Francois joins 60 Degrees Pharmaceuticals (SXTP) board with deep biotech finance background - Stock Titan
Knight Therapeutics (TSX: GUD) reports exit from SXTP, 0 shares as of Mar 31, 2026 - Stock Titan
60 Degrees Pharmaceuticals, Inc. Q1 2026 Financial Results: Net Loss, Operating Expenses, and Key Financial Highlights - Minichart
CVI/Heights report 7.0% stake in 60 Degrees (NASDAQ: SXTP) - Stock Titan
60 Degrees Pharmaceuticals Releases Q1 2026 Financial Results - AlphaStreet
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results - GlobeNewswire
60 Degrees Pharmaceuticals 1Q 2026: Revenue $162.09K, EPS ($1.28) — 10-Q Summary - TradingView
60 Degrees Pharmaceuticals (NASDAQ: SXTP) posts Q1 2026 loss and flags going concern risk - Stock Titan
MSN Money - MSN
TradingKey - TradingKey
SXTP Stock Price, Quote & Chart | 60 DEGREES PHARMA INC (NASDAQ:SXTP) - ChartMill
60 Degrees reports shared 9.1% stake (SXTP) from warrants and holdings - Stock Titan
SXTP Q1'26 Earnings: EPS estimate is (0.76) USD - TradingView
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - ChartMill
The biggest catalyst for 60 Degrees (SXTP) nobody is watching (Momentum Fading) 2026-05-08Ease of Movement - The Legal Advocate
60 Degrees Pharmaceuticals (SXTP) price target decreased by 19.89% to 14.38 - MSN
60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Quantisnow
60 Degrees Pharmaceuticals Inc. (SXTP) upgraded to buy: Here's what you should know - MSN
60 Degrees Pharmaceuticals Inc (SXTP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
60 Degrees Pharmaceuticals Inc 주식 (SXTP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 15 '25 |
Buy |
0.80 |
9,670 |
7,759 |
59,618 |
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
2.60%
0.94%
자본화:
|
볼륨(24시간):